NVO logo

Novo Nordisk A/S (NVO) Cash from investing

annual CFI:

-$18.69B-$12.32B(-193.51%)
December 31, 2024

Summary

  • As of today (August 23, 2025), NVO annual cash flow from investing activities is -$18.69 billion, with the most recent change of -$12.32 billion (-193.51%) on December 31, 2024.
  • During the last 3 years, NVO annual CFI has fallen by -$13.67 billion (-272.09%).
  • NVO annual CFI is now -52292.03% below its all-time high of -$35.68 million, reached on December 1, 1980.

Performance

NVO Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

quarterly CFI:

-$2.11B-$1.17B(-123.80%)
June 1, 2025

Summary

  • As of today (August 23, 2025), NVO quarterly cash flow from investing activities is -$2.11 billion, with the most recent change of -$1.17 billion (-123.80%) on June 1, 2025.
  • Over the past year, NVO quarterly CFI has increased by +$900.07 million (+29.93%).
  • NVO quarterly CFI is now -465.88% below its all-time high of $575.87 million, reached on March 31, 2024.

Performance

NVO quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

TTM CFI:

-$19.31B+$900.07M(+4.45%)
June 1, 2025

Summary

  • As of today (August 23, 2025), NVO TTM cash flow from investing activities is -$19.31 billion, with the most recent change of +$900.07 million (+4.45%) on June 1, 2025.
  • Over the past year, NVO TTM CFI has dropped by -$12.82 billion (-197.63%).
  • NVO TTM CFI is now -136348.41% below its all-time high of $14.17 million, reached on June 30, 2004.

Performance

NVO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVO Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-193.5%+29.9%-197.6%
3 y3 years-272.1%-245.9%-295.1%
5 y5 years-981.6%-943.4%-1326.2%

NVO Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-431.0%at low-465.9%+84.0%-448.6%+4.5%
5 y5-year-981.6%at low-465.9%+84.0%-1326.2%+4.5%
alltimeall time<-9999.0%at low-465.9%+84.0%<-9999.0%+4.5%

NVO Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.11B(+123.8%)
-$19.31B(-4.5%)
Mar 2025
-
-$941.45M(-92.9%)
-$20.21B(+8.1%)
Dec 2024
-$18.69B(+193.5%)
-$13.20B(+331.2%)
-$18.69B(+145.1%)
Sep 2024
-
-$3.06B(+1.8%)
-$7.63B(+17.6%)
Jun 2024
-
-$3.01B(-622.2%)
-$6.49B(+34.2%)
Mar 2024
-
$575.87M(-127.0%)
-$4.83B(-24.1%)
Dec 2023
-$6.37B(+80.9%)
-$2.14B(+11.2%)
-$6.37B(+3.3%)
Sep 2023
-
-$1.92B(+41.9%)
-$6.16B(+24.9%)
Jun 2023
-
-$1.35B(+41.3%)
-$4.94B(+17.8%)
Mar 2023
-
-$958.18M(-50.4%)
-$4.19B(+19.1%)
Dec 2022
-$3.52B(-29.9%)
-$1.93B(+178.6%)
-$3.52B(-27.3%)
Sep 2022
-
-$693.02M(+13.8%)
-$4.84B(-1.0%)
Jun 2022
-
-$609.07M(+111.8%)
-$4.89B(+3.0%)
Mar 2022
-
-$287.52M(-91.2%)
-$4.75B(-5.5%)
Dec 2021
-$5.02B(+46.3%)
-$3.25B(+339.0%)
-$5.02B(+33.3%)
Sep 2021
-
-$740.52M(+58.3%)
-$3.77B(-4.6%)
Jun 2021
-
-$467.94M(-17.1%)
-$3.95B(+7.2%)
Mar 2021
-
-$564.42M(-71.7%)
-$3.69B(+7.4%)
Dec 2020
-$3.43B(+98.7%)
-$2.00B(+116.1%)
-$3.43B(+79.6%)
Sep 2020
-
-$923.59M(+357.4%)
-$1.91B(+41.2%)
Jun 2020
-
-$201.93M(-35.2%)
-$1.35B(-14.2%)
Mar 2020
-
-$311.85M(-34.3%)
-$1.58B(-8.7%)
Dec 2019
-$1.73B(-9.8%)
-$474.68M(+29.9%)
-$1.73B(-8.5%)
Sep 2019
-
-$365.49M(-14.2%)
-$1.89B(-4.2%)
Jun 2019
-
-$426.10M(-7.8%)
-$1.97B(+1.0%)
Mar 2019
-
-$462.03M(-27.2%)
-$1.95B(+1.9%)
Dec 2018
-$1.92B(+91.4%)
-$634.60M(+41.7%)
-$1.92B(+8.2%)
Sep 2018
-
-$447.96M(+10.3%)
-$1.77B(+9.0%)
Jun 2018
-
-$406.04M(-4.8%)
-$1.62B(+22.5%)
Mar 2018
-
-$426.46M(-12.9%)
-$1.33B(+32.5%)
Dec 2017
-$1.00B(-1.2%)
-$489.43M(+61.8%)
-$1.00B(+9.5%)
Sep 2017
-
-$302.44M(+182.0%)
-$913.18M(-9.6%)
Jun 2017
-
-$107.25M(+6.0%)
-$1.01B(+15.8%)
Mar 2017
-
-$101.20M(-74.8%)
-$872.88M(-13.8%)
Dec 2016
-$1.01B(+11.7%)
-$402.28M(+0.7%)
-$1.01B(-22.4%)
Sep 2016
-
-$399.68M(-1419.9%)
-$1.31B(-6.9%)
Jun 2016
-
$30.28M(-112.6%)
-$1.40B(-1.7%)
Mar 2016
-
-$241.03M(-65.3%)
-$1.43B(+57.2%)
Dec 2015
-$906.61M(+146.8%)
-$694.94M(+40.2%)
-$906.61M(+84.9%)
Sep 2015
-
-$495.68M(-8291.8%)
-$490.39M(+166.9%)
Jun 2015
-
$6.05M(-97.8%)
-$183.73M(+10.9%)
Mar 2015
-
$277.96M(-199.7%)
-$165.69M(-54.9%)
Dec 2014
-$367.27M(-25.6%)
-$278.72M(+47.5%)
-$367.27M(+98.8%)
Sep 2014
-
-$189.02M(-884.6%)
-$184.73M(-47.0%)
Jun 2014
-
$24.09M(-68.5%)
-$348.63M(+0.3%)
Mar 2014
-
$76.38M(-179.4%)
-$347.69M(-29.6%)
Dec 2013
-$493.64M(-29.7%)
-$96.18M(-72.7%)
-$493.64M(-27.0%)
Sep 2013
-
-$352.92M(-1510.2%)
-$676.42M(+7.6%)
Jun 2013
-
$25.03M(-136.0%)
-$628.82M(+17.7%)
Mar 2013
-
-$69.57M(-75.1%)
-$534.03M(-24.0%)
Dec 2012
-$702.31M(+8.8%)
-$278.96M(-8.6%)
-$702.31M(-21.6%)
Sep 2012
-
-$305.32M(-354.8%)
-$895.37M(+27.4%)
Jun 2012
-
$119.81M(-150.4%)
-$702.55M(-18.7%)
Mar 2012
-
-$237.84M(-49.6%)
-$864.24M(+33.9%)
Dec 2011
-$645.67M
-$472.03M(+319.6%)
-$645.67M(-20.9%)
DateAnnualQuarterlyTTM
Sep 2011
-
-$112.50M(+168.7%)
-$815.90M(-4.9%)
Jun 2011
-
-$41.87M(+117.3%)
-$857.83M(-9.9%)
Mar 2011
-
-$19.27M(-97.0%)
-$952.23M(-4.1%)
Dec 2010
-$992.74M(+73.5%)
-$642.26M(+315.9%)
-$992.74M(+71.7%)
Sep 2010
-
-$154.43M(+13.3%)
-$578.29M(+0.7%)
Jun 2010
-
-$136.27M(+127.9%)
-$574.09M(+6.8%)
Mar 2010
-
-$59.79M(-73.8%)
-$537.57M(-6.0%)
Dec 2009
-$572.14M(+87.8%)
-$227.81M(+51.6%)
-$572.14M(+43.7%)
Sep 2009
-
-$150.22M(+50.6%)
-$398.28M(+16.8%)
Jun 2009
-
-$99.75M(+5.7%)
-$340.96M(-1.0%)
Mar 2009
-
-$94.37M(+74.9%)
-$344.51M(+13.1%)
Dec 2008
-$304.59M(-44.5%)
-$53.94M(-41.9%)
-$304.59M(-38.8%)
Sep 2008
-
-$92.90M(-10.1%)
-$498.08M(-3.7%)
Jun 2008
-
-$103.30M(+89.7%)
-$517.44M(-1.3%)
Mar 2008
-
-$54.45M(-78.0%)
-$524.43M(-4.4%)
Dec 2007
-$548.58M(+29.5%)
-$247.43M(+120.4%)
-$548.58M(+25.0%)
Sep 2007
-
-$112.26M(+1.8%)
-$438.83M(-5.9%)
Jun 2007
-
-$110.30M(+40.3%)
-$466.39M(-3.6%)
Mar 2007
-
-$78.60M(-42.9%)
-$483.61M(+14.2%)
Dec 2006
-$423.55M(-48.3%)
-$137.67M(-1.5%)
-$423.55M(-34.9%)
Sep 2006
-
-$139.82M(+9.6%)
-$650.23M(-7.9%)
Jun 2006
-
-$127.52M(+587.9%)
-$705.70M(-0.5%)
Mar 2006
-
-$18.54M(-94.9%)
-$709.08M(-13.4%)
Dec 2005
-$818.57M(+145.0%)
-$364.35M(+86.6%)
-$818.57M(+24.9%)
Sep 2005
-
-$195.30M(+49.2%)
-$655.28M(+7.9%)
Jun 2005
-
-$130.90M(+2.2%)
-$607.23M(+78.5%)
Mar 2005
-
-$128.03M(-36.3%)
-$340.21M(+1.8%)
Dec 2004
-$334.13M(-5.0%)
-$201.05M(+36.5%)
-$334.13M(+151.1%)
Sep 2004
-
-$147.25M(-208.2%)
-$133.08M(-1039.0%)
Jun 2004
-
$136.13M(-211.6%)
$14.17M(-111.6%)
Mar 2004
-
-$121.95M
-$121.95M
Dec 2003
-$351.79M(-36.8%)
-
-
Dec 2002
-$556.33M(+12.1%)
-
-
Dec 2001
-$496.25M(+57.8%)
-
-
Dec 2000
-$314.55M(+18.2%)
-
-
Dec 1999
-$266.19M(-16.8%)
-
-
Dec 1998
-$319.77M(-13.4%)
-
-
Dec 1997
-$369.24M(+7.7%)
-
-
Dec 1996
-$342.89M(+89.6%)
-
-
Dec 1995
-$180.88M(-39.7%)
-
-
Dec 1994
-$300.09M(-25.0%)
-
-
Dec 1993
-$400.24M(+12.4%)
-
-
Dec 1992
-$356.09M(+46.4%)
-
-
Dec 1991
-$243.17M(+21.8%)
-
-
Dec 1990
-$199.63M(+49.1%)
-
-
Dec 1989
-$133.92M(+15.6%)
-
-
Dec 1988
-$115.84M(+0.9%)
-
-
Dec 1987
-$114.80M(+18.3%)
-
-
Dec 1986
-$97.01M(+50.1%)
-
-
Dec 1985
-$64.63M(+5.8%)
-
-
Dec 1984
-$61.06M(-0.8%)
-
-
Dec 1983
-$61.52M(+3.7%)
-
-
Dec 1982
-$59.35M(+39.6%)
-
-
Dec 1981
-$42.52M(+19.2%)
-
-
Dec 1980
-$35.68M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash flow from investing activities?
  • What is the all time high annual CFI for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual CFI year-on-year change?
  • What is Novo Nordisk A/S quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly CFI year-on-year change?
  • What is Novo Nordisk A/S TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM CFI year-on-year change?

What is Novo Nordisk A/S annual cash flow from investing activities?

The current annual CFI of NVO is -$18.69B

What is the all time high annual CFI for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash flow from investing activities is -$35.68M

What is Novo Nordisk A/S annual CFI year-on-year change?

Over the past year, NVO annual cash flow from investing activities has changed by -$12.32B (-193.51%)

What is Novo Nordisk A/S quarterly cash flow from investing activities?

The current quarterly CFI of NVO is -$2.11B

What is the all time high quarterly CFI for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash flow from investing activities is $575.87M

What is Novo Nordisk A/S quarterly CFI year-on-year change?

Over the past year, NVO quarterly cash flow from investing activities has changed by +$900.07M (+29.93%)

What is Novo Nordisk A/S TTM cash flow from investing activities?

The current TTM CFI of NVO is -$19.31B

What is the all time high TTM CFI for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash flow from investing activities is $14.17M

What is Novo Nordisk A/S TTM CFI year-on-year change?

Over the past year, NVO TTM cash flow from investing activities has changed by -$12.82B (-197.63%)
On this page